GOLPH3: a novel biomarker that correlates with poor survival and resistance to chemotherapy in breast cancer

The association between Golgi phosphoprotein 3 (GOLPH3) and clinical pathological characteristics, as well as the clinical outcomes of both neoadjuvant and adjuvant chemotherapies in breast cancer, remain largely unknown. In this study, we investigated the biological role and clinical significance o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Shicong, Pan, Hong, Wei, Wei, Yang, Huawei, Liu, Jianlun, Yang, Rirong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739628/
https://www.ncbi.nlm.nih.gov/pubmed/29285241
http://dx.doi.org/10.18632/oncotarget.21927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739628/
https://www.ncbi.nlm.nih.gov/pubmed/29285241
http://dx.doi.org/10.18632/oncotarget.21927

Ejemplares similares